{
  "sample": true,
  "notice": "Frozen live-source example. No payment was made. Metadata only; not a clinical conclusion.",
  "capturedAt": "2026-10-07T08:50:43.059Z",
  "brief": {
    "query": "semaglutide obesity",
    "generatedAt": "2026-10-07T08:50:42.496Z",
    "literature": {
      "query": "semaglutide obesity",
      "fromYear": null,
      "papers": [
        {
          "id": "doi:10.31274/cc-20240624-1097",
          "doi": "10.31274/cc-20240624-1097",
          "title": "Overview of Semaglutide on Obesity Treatment",
          "authors": ["Kyleigh Hanzlik"],
          "year": 2024,
          "journal": null,
          "publicationTypes": ["report"],
          "sources": ["Crossref"],
          "sourceLinks": [
            {
              "source": "Crossref",
              "url": "https://api.crossref.org/works/10.31274%2Fcc-20240624-1097"
            },
            {
              "source": "Publisher DOI",
              "url": "https://doi.org/10.31274/cc-20240624-1097"
            }
          ],
          "abstractAvailable": false,
          "openAccess": null,
          "integritySignals": []
        },
        {
          "id": "doi:10.1002/psb.0010096",
          "doi": "10.1002/psb.0010096",
          "title": "NICE recommends semaglutide for managing obesity",
          "authors": [],
          "year": 2023,
          "journal": "News Digital Object Group",
          "publicationTypes": ["dataset"],
          "sources": ["Crossref"],
          "sourceLinks": [
            {
              "source": "Crossref",
              "url": "https://api.crossref.org/works/10.1002%2Fpsb.0010096"
            },
            {
              "source": "Publisher DOI",
              "url": "https://doi.org/10.1002/psb.0010096"
            }
          ],
          "abstractAvailable": false,
          "openAccess": null,
          "integritySignals": []
        },
        {
          "id": "doi:10.31579/2768-0487/015",
          "doi": "10.31579/2768-0487/015",
          "title": "Once weekly semaglutide for treatment of obesity",
          "authors": ["Nasser Mikhail"],
          "year": 2021,
          "journal": "Journal of Clinical and Laboratory Research",
          "publicationTypes": ["journal-article"],
          "sources": ["Crossref"],
          "sourceLinks": [
            {
              "source": "Crossref",
              "url": "https://api.crossref.org/works/10.31579%2F2768-0487%2F015"
            },
            {
              "source": "Publisher DOI",
              "url": "https://doi.org/10.31579/2768-0487/015"
            }
          ],
          "abstractAvailable": true,
          "openAccess": null,
          "integritySignals": []
        },
        {
          "id": "doi:10.1530/obabs.3.ou2",
          "doi": "10.1530/obabs.3.ou2",
          "title": "Semaglutide and beyond: An update on pharmacotherapy for obesity",
          "authors": ["John Wilding"],
          "year": 2021,
          "journal": "Obesity Abstracts",
          "publicationTypes": ["journal-article"],
          "sources": ["Crossref"],
          "sourceLinks": [
            {
              "source": "Crossref",
              "url": "https://api.crossref.org/works/10.1530%2Fobabs.3.ou2"
            },
            {
              "source": "Publisher DOI",
              "url": "https://doi.org/10.1530/obabs.3.ou2"
            }
          ],
          "abstractAvailable": false,
          "openAccess": null,
          "integritySignals": []
        },
        {
          "id": "doi:10.62830/mmj3-02-20c",
          "doi": "10.62830/mmj3-02-20c",
          "title": "Integrating Chrono-Nutrition with Oral Semaglutide Therapy in the Management of Extreme Obesity: A Case Report",
          "authors": ["Purva Singh"],
          "year": 2026,
          "journal": "Integrating Chrono-Nutrition with Oral Semaglutide Therapy in the Management of Extreme Obesity: A Case Report",
          "publicationTypes": ["journal-article"],
          "sources": ["Crossref"],
          "sourceLinks": [
            {
              "source": "Crossref",
              "url": "https://api.crossref.org/works/10.62830%2Fmmj3-02-20c"
            },
            {
              "source": "Publisher DOI",
              "url": "https://doi.org/10.62830/mmj3-02-20c"
            }
          ],
          "abstractAvailable": true,
          "openAccess": null,
          "integritySignals": []
        }
      ],
      "sourceStatus": [
        {
          "source": "Crossref",
          "status": "ok",
          "retrievedAt": "2026-10-07T08:50:42.228Z"
        },
        {
          "source": "Europe PMC",
          "status": "ok",
          "retrievedAt": "2026-10-07T08:50:40.633Z"
        }
      ],
      "partial": false,
      "rankingMethod": "Title token overlap after combining source-ranked candidate sets; not a scientific quality score.",
      "limitations": [
        "Metadata search is not an exhaustive systematic review; results are a bounded retrieval set.",
        "Study types are source labels, not independent methodological appraisal or certainty ratings.",
        "A missing retraction signal does not establish that a paper is unretracted or reliable.",
        "Source data may be incomplete or delayed. Check publisher notices and original papers.",
        "Publisher abstracts and full text are not redistributed. Follow the source links for findings."
      ]
    },
    "clinicalTrials": {
      "_evidence402RetrievedAt": "2026-10-07T08:50:39.572Z",
      "totalMatching": 416,
      "studies": [
        {
          "id": "NCT05829460",
          "title": "Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia",
          "status": "WITHDRAWN",
          "phase": ["PHASE2"],
          "studyType": "INTERVENTIONAL",
          "enrollment": {
            "count": 0,
            "type": "ACTUAL"
          },
          "conditions": ["Endometrial Hyperplasia"],
          "interventions": [
            {
              "type": "DRUG",
              "name": "Semaglutide"
            },
            {
              "type": "DRUG",
              "name": "Placebo"
            },
            {
              "type": "DRUG",
              "name": "LNG-IUD (Progestin)"
            },
            {
              "type": "BEHAVIORAL",
              "name": "Telemedicine behavioral weight program"
            }
          ],
          "resultsPosted": false,
          "lastUpdate": "2026-01-12",
          "url": "https://clinicaltrials.gov/study/NCT05829460"
        },
        {
          "id": "NCT07586150",
          "title": "Personalized Pharmaco-Lifestyle Interventions for Severe Mental Illnesses (LIFETRAIN)",
          "status": "NOT_YET_RECRUITING",
          "phase": ["NA"],
          "studyType": "INTERVENTIONAL",
          "enrollment": {
            "count": 140,
            "type": "ESTIMATED"
          },
          "conditions": [
            "Severe Mental Illness",
            "Depression / Major Depressive Disorder",
            "Bipolar Disorder (BD)",
            "Schizophrenia"
          ],
          "interventions": [
            {
              "type": "DRUG",
              "name": "Semaglutide (SEMA)"
            },
            {
              "type": "BEHAVIORAL",
              "name": "Exercise module"
            },
            {
              "type": "BEHAVIORAL",
              "name": "Anti-inflammatory diet module"
            },
            {
              "type": "BEHAVIORAL",
              "name": "Sleep intervention module"
            },
            {
              "type": "BEHAVIORAL",
              "name": "Social prescribing module"
            },
            {
              "type": "DEVICE",
              "name": "Closed-loop transcranial alternating current stimulation (CL-tACS)"
            },
            {
              "type": "BEHAVIORAL",
              "name": "Structured lifestyle psychoeducation"
            },
            {
              "type": "DEVICE",
              "name": "Sham CL-tACS"
            }
          ],
          "resultsPosted": false,
          "lastUpdate": "2026-05-14",
          "url": "https://clinicaltrials.gov/study/NCT07586150"
        },
        {
          "id": "NCT05236517",
          "title": "A Research Study Looking at How 50 mg Semaglutide Daily Affects Food Intake and Emptying of the Stomach in People With Obesity",
          "status": "COMPLETED",
          "phase": ["PHASE1"],
          "studyType": "INTERVENTIONAL",
          "enrollment": {
            "count": 60,
            "type": "ACTUAL"
          },
          "conditions": ["Obesity"],
          "interventions": [
            {
              "type": "DRUG",
              "name": "Semaglutide D Dose 1"
            },
            {
              "type": "DRUG",
              "name": "Semaglutide D Dose 2"
            },
            {
              "type": "DRUG",
              "name": "Semaglutide D Dose 3"
            },
            {
              "type": "DRUG",
              "name": "Semaglutide C Dose 4"
            },
            {
              "type": "DRUG",
              "name": "Semaglutide C Dose 5 (50 mg)"
            },
            {
              "type": "DRUG",
              "name": "Placebo (Semaglutide C)"
            },
            {
              "type": "DRUG",
              "name": "Placebo ( Semaglutide D)"
            }
          ],
          "resultsPosted": false,
          "lastUpdate": "2024-09-19",
          "url": "https://clinicaltrials.gov/study/NCT05236517"
        },
        {
          "id": "NCT07511543",
          "title": "Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke Thrombectomy",
          "status": "NOT_YET_RECRUITING",
          "phase": ["PHASE2"],
          "studyType": "INTERVENTIONAL",
          "enrollment": {
            "count": 100,
            "type": "ESTIMATED"
          },
          "conditions": ["Ischemic Stroke"],
          "interventions": [
            {
              "type": "DRUG",
              "name": "Semaglutide"
            }
          ],
          "resultsPosted": false,
          "lastUpdate": "2026-09-24",
          "url": "https://clinicaltrials.gov/study/NCT07511543"
        },
        {
          "id": "NCT06354101",
          "title": "The Purpose of This Registry Study is to Learn More About Metabolic Health: Approximately 15,000 Participants Who Are Overweight or Have Obesity With or Without Metabolic Diseases Are Expected to Participate in This Registry Study.",
          "status": "WITHDRAWN",
          "phase": [],
          "studyType": "OBSERVATIONAL",
          "enrollment": {
            "count": 0,
            "type": "ACTUAL"
          },
          "conditions": ["Metabolic Health"],
          "interventions": [
            {
              "type": "DRUG",
              "name": "Tirzepatide"
            },
            {
              "type": "DRUG",
              "name": "Semaglutide"
            }
          ],
          "resultsPosted": false,
          "lastUpdate": "2024-04-09",
          "url": "https://clinicaltrials.gov/study/NCT06354101"
        }
      ]
    },
    "sourceStatus": [
      {
        "source": "Crossref",
        "status": "ok",
        "retrievedAt": "2026-10-07T08:50:42.228Z"
      },
      {
        "source": "Europe PMC",
        "status": "ok",
        "retrievedAt": "2026-10-07T08:50:40.633Z"
      },
      {
        "source": "ClinicalTrials.gov",
        "status": "ok",
        "retrievedAt": "2026-10-07T08:50:39.572Z"
      }
    ],
    "partial": false,
    "evidenceMap": {
      "retrievedPapers": 5,
      "publicationTypeCounts": {
        "report": 1,
        "dataset": 1,
        "journal-article": 3
      },
      "missingDoi": 0,
      "integritySignals": []
    },
    "bibliography": [
      {
        "ref": "S1",
        "paperId": "doi:10.31274/cc-20240624-1097",
        "citation": "Kyleigh Hanzlik. Overview of Semaglutide on Obesity Treatment. Journal not supplied. 2024. doi:10.31274/cc-20240624-1097",
        "url": "https://doi.org/10.31274/cc-20240624-1097"
      },
      {
        "ref": "S2",
        "paperId": "doi:10.1002/psb.0010096",
        "citation": "Author not supplied. NICE recommends semaglutide for managing obesity. News Digital Object Group. 2023. doi:10.1002/psb.0010096",
        "url": "https://doi.org/10.1002/psb.0010096"
      },
      {
        "ref": "S3",
        "paperId": "doi:10.31579/2768-0487/015",
        "citation": "Nasser Mikhail. Once weekly semaglutide for treatment of obesity. Journal of Clinical and Laboratory Research. 2021. doi:10.31579/2768-0487/015",
        "url": "https://doi.org/10.31579/2768-0487/015"
      },
      {
        "ref": "S4",
        "paperId": "doi:10.1530/obabs.3.ou2",
        "citation": "John Wilding. Semaglutide and beyond: An update on pharmacotherapy for obesity. Obesity Abstracts. 2021. doi:10.1530/obabs.3.ou2",
        "url": "https://doi.org/10.1530/obabs.3.ou2"
      },
      {
        "ref": "S5",
        "paperId": "doi:10.62830/mmj3-02-20c",
        "citation": "Purva Singh. Integrating Chrono-Nutrition with Oral Semaglutide Therapy in the Management of Extreme Obesity: A Case Report. Integrating Chrono-Nutrition with Oral Semaglutide Therapy in the Management of Extreme Obesity: A Case Report. 2026. doi:10.62830/mmj3-02-20c",
        "url": "https://doi.org/10.62830/mmj3-02-20c"
      }
    ],
    "nextChecks": [
      "Read the original studies and extract population, intervention, comparator, outcomes and limitations.",
      "Check all flagged publication updates at the publisher.",
      "Assess bias, consistency and relevance before forming a conclusion."
    ],
    "limitations": [
      "Metadata search is not an exhaustive systematic review; results are a bounded retrieval set.",
      "Study types are source labels, not independent methodological appraisal or certainty ratings.",
      "A missing retraction signal does not establish that a paper is unretracted or reliable.",
      "Source data may be incomplete or delayed. Check publisher notices and original papers.",
      "Publisher abstracts and full text are not redistributed. Follow the source links for findings.",
      "Registry records describe registered studies and may not have posted results; registration is not proof of effectiveness.",
      "No clinical conclusions or invented narrative are generated from metadata."
    ],
    "markdown": "# Research evidence pack\n\nQuery: semaglutide obesity\n\nThis is a metadata retrieval pack, not a synthesis of study findings.\n\n## Retrieved papers\n\n- [S1] Overview of Semaglutide on Obesity Treatment (2024). Types: report.\n- [S2] NICE recommends semaglutide for managing obesity (2023). Types: dataset.\n- [S3] Once weekly semaglutide for treatment of obesity (2021). Types: journal-article.\n- [S4] Semaglutide and beyond: An update on pharmacotherapy for obesity (2021). Types: journal-article.\n- [S5] Integrating Chrono-Nutrition with Oral Semaglutide Therapy in the Management of Extreme Obesity: A Case Report (2026). Types: journal-article.\n\n## References\n\n- [S1] Kyleigh Hanzlik. Overview of Semaglutide on Obesity Treatment. Journal not supplied. 2024. doi:10.31274/cc-20240624-1097 https://doi.org/10.31274/cc-20240624-1097\n- [S2] Author not supplied. NICE recommends semaglutide for managing obesity. News Digital Object Group. 2023. doi:10.1002/psb.0010096 https://doi.org/10.1002/psb.0010096\n- [S3] Nasser Mikhail. Once weekly semaglutide for treatment of obesity. Journal of Clinical and Laboratory Research. 2021. doi:10.31579/2768-0487/015 https://doi.org/10.31579/2768-0487/015\n- [S4] John Wilding. Semaglutide and beyond: An update on pharmacotherapy for obesity. Obesity Abstracts. 2021. doi:10.1530/obabs.3.ou2 https://doi.org/10.1530/obabs.3.ou2\n- [S5] Purva Singh. Integrating Chrono-Nutrition with Oral Semaglutide Therapy in the Management of Extreme Obesity: A Case Report. Integrating Chrono-Nutrition with Oral Semaglutide Therapy in the Management of Extreme Obesity: A Case Report. 2026. doi:10.62830/mmj3-02-20c https://doi.org/10.62830/mmj3-02-20c\n\n## Limits\n\n- Metadata search is not an exhaustive systematic review; results are a bounded retrieval set.\n- Study types are source labels, not independent methodological appraisal or certainty ratings.\n- A missing retraction signal does not establish that a paper is unretracted or reliable.\n- Source data may be incomplete or delayed. Check publisher notices and original papers.\n- Publisher abstracts and full text are not redistributed. Follow the source links for findings.\n- Registry records describe registered studies and may not have posted results; registration is not proof of effectiveness.\n- No clinical conclusions or invented narrative are generated from metadata.\n"
  },
  "verify": {
    "citations": [
      {
        "doi": "10.1056/nejmoa2032183",
        "existence": "found",
        "paper": {
          "id": "doi:10.1056/nejmoa2032183",
          "doi": "10.1056/nejmoa2032183",
          "title": "Once-Weekly Semaglutide in Adults with Overweight or Obesity",
          "authors": [
            "John P.H. Wilding",
            "Rachel L. Batterham",
            "Salvatore Calanna",
            "Melanie Davies",
            "Luc F. Van Gaal",
            "Ildiko Lingvay",
            "Barbara M. McGowan",
            "Julio Rosenstock",
            "Marie T.D. Tran",
            "Thomas A. Wadden",
            "Sean Wharton",
            "Koutaro Yokote",
            "Niels Zeuthen",
            "Robert F. Kushner"
          ],
          "year": 2021,
          "journal": "New England Journal of Medicine",
          "publicationTypes": [
            "journal-article",
            "Research Support, Non-U.S. Gov't",
            "Multicenter Study",
            "Randomized Controlled Trial",
            "Journal Article"
          ],
          "sources": ["Crossref", "Europe PMC"],
          "sourceLinks": [
            {
              "source": "Crossref",
              "url": "https://api.crossref.org/works/10.1056%2Fnejmoa2032183"
            },
            {
              "source": "Publisher DOI",
              "url": "https://doi.org/10.1056/nejmoa2032183"
            },
            {
              "source": "Europe PMC",
              "url": "https://europepmc.org/article/MED/33567185"
            }
          ],
          "abstractAvailable": true,
          "openAccess": false,
          "integritySignals": []
        },
        "sourceStatus": [
          {
            "source": "Crossref",
            "status": "ok",
            "retrievedAt": "2026-10-07T08:50:42.640Z"
          },
          {
            "source": "Europe PMC",
            "status": "ok",
            "retrievedAt": "2026-10-07T08:50:42.807Z"
          }
        ],
        "titleCheck": {
          "status": "likely_match",
          "similarity": 1,
          "method": "Token Dice similarity; author/year/content are not verified."
        },
        "integrity": {
          "status": "no_signal_in_checked_metadata",
          "signals": []
        }
      }
    ],
    "partial": false,
    "limitations": [
      "Metadata search is not an exhaustive systematic review; results are a bounded retrieval set.",
      "Study types are source labels, not independent methodological appraisal or certainty ratings.",
      "A missing retraction signal does not establish that a paper is unretracted or reliable.",
      "Source data may be incomplete or delayed. Check publisher notices and original papers.",
      "Publisher abstracts and full text are not redistributed. Follow the source links for findings.",
      "Not found only means absent from Crossref and Europe PMC; other DOI registries such as DataCite are not checked."
    ]
  }
}